Evolution of Vaginal Candida Species Recovered from Human Immunodeficiency Virus‐Infected Women Receiving Fluconazole Prophylaxis: The Emergence of Candida glabrata?
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
The effect of fluconazole prophylaxis on the vaginal flora of 323 human immunodeficiency virus-infected women was evaluated in a multicenter, randomized, double-blind, placebo-controlled trial. Women with CD4 cell counts of < or = 300/mm3 received either 200 mg of fluconazole per week or placebo. Vaginal surveillance cultures were performed every 3 months. After a follow-up of 29 months, Candida albicans was recovered from 53% of patients receiving fluconazole and 68% of patients assigned placebo. Fluconazole was associated with a 50% reduction in the odds of being colonized with C. albicans but with higher rates for non-albicans Candida species. Candida glabrata was recovered from 40 women assigned fluconazole and 29 assigned placebo (relative odds, 1.96; 95% confidence interval, 0.98-3.94). Fluconazole had an early and persistent effect on the vaginal mycoflora, with the emergence of C. glabrata vaginal colonization within the first 6 months. The effect of fluconazole prophylaxis can be attributed to the reduction in vaginal C. albicans colonization; however, C. glabrata colonization rapidly supervened.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“there was a statistically significant increase in the rate of infections due to Candida glabrata, which is now the second most common cause of bloodstream and mucosal infections in the United States (6, 48, 65, 69).”
From Functional Genomic Analysis of Fluconazole Susceptibility in the Pathogenic Yeast Candida glabrata : Roles of Calcium Signaling and Mitochondria (2004) · cites this paper as [69]
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Plackett, R. L., & Cox, D. R. (1971) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2344247 · Cited by 2,264 · cited 1×
“multivariate logistic regression analysis [17].”
Generalized linear mixed models a pseudo-likelihood approach
Wolfinger, R., & O'connell, M. (1993) · Journal of Statistical Computation and Simulation · doi:10.1080/00949659308811554 · Cited by 1,271
Wingard, J. R., Merz, W. G., Rinaldi, M. G., Johnson, T. R., Karp, J. E., & Saral, R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110313251803 · Cited by 937
Klein, R. S., Harris, C. A., Small, C. B., Moll, B., Lesser, M., & Friedland, G. H. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408093110602 · Cited by 863 · cited 1×
“perficial (mucosal) infections, produced by opportunistic fungal pathogens belonging to the Candida species [1-4].”
BackgroundEdwards, Jr., Bodey, G. P., Bowden, R. A., Buchner, T., de Pauw, B. E., Filler, S. G., Ghannoum, M. A., Glauser, M., Herbrecht, R., Kauffman, C. A., et al. (1997) · Clinical Infectious Diseases · doi:10.1086/514504 · Cited by 418 · cited 1×
“[24].”
Wingard, J. R., Merz, W. G., Rinaldi, M. G., Miller, C. B., Karp, J. E., & Saral, R. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.9.1847 · Cited by 340
Sangeorzan, J. A., Bradley, S. F., He, X., Zarins, L. T., Ridenour, G. L., Tiballi, R. N., & Kauffman, C. A. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90300-x · Cited by 322 · cited 1×
“Both the increased incidence in fungal infections and the consequent increased use of antifungals are thought to select for fungal populations that are more resistant to antifungals [19-22].”
BackgroundPowderly, W. G., Finkelstein, D. M., Feinberg, J., Frame, P., He, W., van der Horst, C., Koletar, S. L., Eyster, M. E., Carey, J., Waskin, H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503163321102 · Cited by 318 · cited 4×
“recently performed a prospective, randomized trial comparing fluconazole (200 mg/d) with clotrimazole troches [13].”
BackgroundInfluentialOpportunistic diseases reported in AIDS patients: frequencies, associations, and trends.
Selik, R. M., Starcher, E. T., & Curran, J. W. (1987) · PubMed · Cited by 270
Johnson, E. M., Warnock, D. W., Luker, J., Porter, S. R., & Scully, C. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/35.1.103 · Cited by 259 · cited 1×
“[26] reported that six of 22 patients who receiving long-term fluconazole harbored two species on the same or different occasions.”
BackgroundThe Growing Problem of Mycoses in Patients Infected with the Human Immunodeficiency Virus
Diamond, R. D. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.3.480 · Cited by 153 · cited 2×
“perficial (mucosal) infections, produced by opportunistic fungal pathogens belonging to the Candida species [1-4].”
BackgroundRisk Factors for Fluconazole-Resistant Candidiasis in Human Immunodeficiency Virus-Infected Patients
Maenza, J. R., Keruly, J. C., Moore, R. D., Chaisson, R. E., Merz, W. G., & Gallant, J. E. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.1.219 · Cited by 150
Infection Due to Fluconazole-Resistant Candida in Patients with AIDS: Prevalence and Microbiology
Maenza, J. R., Merz, W. G., Romagnoli, M. J., Keruly, J. C., Moore, R. D., & Gallant, J. E. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.1.28 · Cited by 141 · cited 2×
“that assessed the microbiology of oral infection in AIDS patients, there was a trend toward the recovery of non-albicans Candida species alone or in combination with other Candida species when CHROMagar Candida medium (CHROMager Microbiology, Paris) was utilized rather than the standard Sabouraud dextrose agar medium…”
BackgroundMethodLaine, L., Dretler, R. H., Conteas, C. N., Tuazon, C., Koster, F. M., Sattler, F., Squires, K., & Islam, M. Z. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-8-655 · Cited by 131 · cited 1×
“in patients with AIDS, producing a more rapid clinical and mycologic response than observed with other azoles [5-7].”
ResultPaugam, A., Dupouy-Camet, J., Blanche, P., Gangneux, J. P., Tourte-Schaefer, C., & Sicard, D. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/19.5.975-a · Cited by 117
Oral Candida albicans in HIV Infection
Torssander, J., Morfeldt-Månson, L., Biberfeld, G., Karlsson, A., Putkonen, P.-O., & Wasserman, J. (1987) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548709018473 · Cited by 107 · cited 1×
“Fungal infections are among the most common opportunistic Previously, only alterations in the gastrointestinal microbial flora of hospitalized neutropenic patients receiving long-term complications in persons infected with HIV type 1 (HIV) [1, 2].”
BackgroundKoletar, S. L., Russell, J. A., Fass, R. J., & Plouffe, J. F. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.11.2267 · Cited by 102
Factors associated with increased frequency of HIV‐related oral candidiasis
McCarthy, G. M., Mackie, I. D. F., Koval, J. J., Sandhu, H. S., & Daley, T. D. (1991) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.1991.tb00940.x · Cited by 102 · cited 1×
“As in previously published studies, in which increased baseline fungal colonization rates were correlated with lower CD4+ cell counts [22, 25], our data showed that among patients with a 50-cell/mm3-lower CD4+ cell count, there was an 11% increase in the vaginal fungal colonization rate.”
ResultFluconazole-Resistant Candida albicans After Long-term Suppressive Therapy
Sanguineti, A. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.9.1122 · Cited by 95
Pons, V., Greenspan, D., & Debruin, M. (1993) · PubMed · Cited by 93
Fluconazole resistance in Candida in patients with AIDS—A therapeutic approach
Ng, T., & Denning, D. W. (1993) · Journal of Infection · doi:10.1016/0163-4453(93)92707-4 · Cited by 83 · cited 2×
“As in previously published studies, in which increased baseline fungal colonization rates were correlated with lower CD4+ cell counts [22, 25], our data showed that among patients with a 50-cell/mm3-lower CD4+ cell count, there was an 11% increase in the vaginal fungal colonization rate.”
BackgroundResultLeen, C. L. S., Dunbar, E. M., Ellis, M. E., & Mandal, B. K. (1990) · Journal of Infection · doi:10.1016/0163-4453(90)90646-p · Cited by 73
Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients
Just‐Nübling, G., Gentschew, G., Meißner, K., Odewald, J., Staszewski, S., Helm, E. B., & Stille, W. (1991) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02005444 · Cited by 70
Disseminated Candidiasis Due to Amphotericin B-Resistant Candida albicans
Conly, J., Rennie, R., Johnson, J., Farah, S., & Hellman, L. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/165.4.761 · Cited by 64 · cited 1×
“albicans and non-albicans Candida species, are capable of producing debilitating disease that is difficult if not impossible to eradicate [21, 23].”
BackgroundStevens, D. A. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400120096018 · Cited by 48
Marriott, D. J. E., Harkness, J. L., Jones, P. D., Hoy, J. F., & Speed, B. R. (1993) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1993.tb121784.x · Cited by 40 · cited 1×
“In addition, daily or intermittent doses of fluconazole have been shown to be effective in preventing mucosal candidiasis in AIDS patients [8-13].”
BackgroundJust, G., Steinheimer, D., Schnellbach, M., Böttinger, C., Helm, E. B., & Stille, W. (1989) · Mycoses · doi:10.1111/j.1439-0507.1989.tb02310.x · Cited by 23
Cited by
Guidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440
“Chronic use of fluconazole in HIV-infected women has been associated with increased vaginal carriage of non-albicans species of Candida [320], but the significance of this observation is uncertain.”
BackgroundSelf-citationEpidemiology of Candida species infections in critically ill non-immunosuppressed patients
Eggimann, P., Garbino, J., & Pittet, D. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00801-6 · Cited by 900
A yeast by any other name: Candida glabrata and its interaction with the host
Kaur, R., Domergue, R., Zupancic, M. L., & Cormack, B. P. (2005) · Current Opinion in Microbiology · doi:10.1016/j.mib.2005.06.012 · Cited by 271
De Las Peñas, A., Pan, S.-J., Castaño, I., Alder, J., Cregg, R., & Cormack, B. P. (2003) · Genes & Development · doi:10.1101/gad.1121003 · Cited by 268
“C. glabrata, a haploid yeast, accounts for upwards of 15% of isolates from the bloodstream as well as from mucosal sites (Schuman et al. 1998; Pfaller et al. 1999, 2001; Vazquez et al. 1999).”
BackgroundNicotinic Acid Limitation Regulates Silencing of Candida Adhesins During UTI
Domergue, R., Castaño, I., De Las Peñas, A., Zupancic, M., Lockatell, V., Hebel, J. R., Johnson, D., & Cormack, B. P. (2005) · Science · doi:10.1126/science.1108640 · Cited by 249
Metadata
- Authors
- Vazquez, J. A., Sobel, J. D., Peng, G., Steele‐Moore, L., Schuman, P., Holloway, W., Neaton, J. D., & (CPCRA), T. T. B. C. P. F. C. R. I. A.
- Affiliations
- Wayne State University (US)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-05
- Volume
- 28
- Issue
- 5
- Pages
- 1025-1031
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2131249166
- Cited by
- 51
- References
- 28
- Citations by year
- 2021: 2 · 2018: 4 · 2017: 1 · 2015: 1 · 2014: 2 · 2013: 1 · 2012: 1
- FWCI
- 3.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Keywords
- fluconazole prophylaxis, Candida glabrata, Candida albicans, vaginal candidiasis, HIV infection, non-albicans Candida, antifungal prophylaxis, candidal colonization, CD4 count
- MeSH terms
- Antifungal Agents, Candida, Candida albicans, Candidiasis, Vulvovaginal, Double-Blind Method, Female, Humans, Risk Factors, Fluconazole, AIDS-Related Opportunistic Infections, CD4 Lymphocyte Count, Antibiotic Prophylaxis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.